|
1
|
World Health Organization: International
Agency For Research on Cancer: Cancer Today. Data visualization
tools for exploring the global cancer burden in 2020. https://gco.iarc.fr/today/home
|
|
2
|
Song M and Chan AT: Environmental factors,
gut microbiota, and colorectal cancer prevention. Clin
Gastroenterol Hepatol. 17:275–289. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dong Y, Zhou J, Zhu Y, Luo L, He T, Hu H,
Liu H, Zhang Y, Luo D, Xu S, et al: Abdominal obesity and
colorectal cancer risk: Systematic review and meta-analysis of
prospective studies. Biosci Rep. Dec 12–2017.(Epub ahead of print).
doi: 10.1042/BSR20170945. View Article : Google Scholar
|
|
4
|
Keum N and Giovannucci E: Global burden of
colorectal cancer: Emerging trends, risk factors and prevention
strategies. Nat Rev Gastroenterol Hepatol. 16:713–732. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Balacescu O, Sur D, Cainap C, Visan S,
Cruceriu D, Manzat-Saplacan R, Muresan MS, Balacescu L, Lisencu C
and Irimie A: The impact of miRNA in colorectal cancer progression
and its liver metastases. Int J Mol Sci. 19:37112018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Riihimäki M, Hemminki A, Sundquist J and
Hemminki K: Patterns of metastasis in colon and rectal cancer. Sci
Rep. 6:297652016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peng Y and Croce CM: The role of MicroRNAs
in human cancer. Signal Transduct Target Ther. 1:150042016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jin XH, Lu S and Wang AF: Expression and
clinical significance of miR-4516 and miR-21-5p in serum of
patients with colorectal cancer. BMC Cancer. 20:2412020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Strubberg AM and Madison BB: MicroRNAs in
the etiology of colorectal cancer: Pathways and clinical
implications. Dis Model Mech. 10:197–214. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jung G, Hernández-Illán E, Moreira L,
Balaguer F and Goel A: Epigenetics of colorectal cancer: Biomarker
and therapeutic potential. Nat Rev Gastroenterol Hepatol.
17:111–130. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cojocneanu R, Braicu C, Raduly L, Jurj A,
Zanoaga O, Magdo L, Irimie A, Muresan MS, Ionescu C, Grigorescu M
and Berindan-Neagoe I: Plasma and tissue specific miRNA expression
pattern and functional analysis associated to colorectal cancer
patients. Cancers (Basel). 12:8432020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ghareib AF, Mohamed RH, Abd El-Fatah AR
and Saadawy SF: Assessment of serum MicroRNA-21 gene expression for
diagnosis and prognosis of colorectal cancer. J Gastrointest
Cancer. 51:818–823. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wan TM, Iyer DN and Ng L: Roles of
microRNAs as non-invasive biomarker and therapeutic target in
colorectal cancer. Histol Histopathol. 35:225–237. 2020.PubMed/NCBI
|
|
14
|
Locker GY, Hamilton S, Harris J, Jessup
JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF and Bast RC Jr:
ASCO: ASCO 2006 update of recommendations for the use of tumor
markers in gastrointestinal cancer. J Clin Oncol. 24:5313–5327.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Duffy MJ, van Dalen A, Haglund C, Hansson
L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C
and Topolcan O: Tumour markers in colorectal cancer: European Group
on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer.
43:1348–1360. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tan E, Gouvas N, Nicholls RJ, Ziprin P,
Xynos E and Tekkis PP: Diagnostic precision of carcinoembryonic
antigen in the detection of recurrence of colorectal cancer. Surg
Oncol. 18:15–24. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pesta M, Kucera R, Topolcan O, et al:
Plasma microRNA levels combined with CEA and CA19-9 in the
follow-up of colorectal cancer patients. Cancers (Basel).
11:E8642019. View Article : Google Scholar
|
|
18
|
Iorio MV and Croce CM: microRNA
involvement in human cancer. Carcinogenesis. 33:1126–1133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Piccinini AM and Midwood KS: Endogenous
control of immunity against infection: Tenascin-C regulates
TLR4-mediated inflammation via microRNA-155. Cell Rep. 2:914–926.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tili E, Michaille JJ and Croce CM:
MicroRNAs play a central role in molecular dysfunctions linking
inflammation with cancer. Immunol Rev. 253:167–184. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ristau J, Staffa J, Schrotz-King P, Gigic
B, Makar KW, Hoffmeister M, Brenner H, Ulrich A, Schneider M,
Ulrich CM and Habermann N: Suitability of circulating miRNAs as
potential prognostic markers in colorectal cancer. Cancer Epidemiol
Biomark Prev. 23:2632–2637. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen B, Xia Z, Deng YN, Yang Y, Zhang P,
Zhu H, Xu N and Liang S: Emerging microRNA biomarkers for
colorectal cancer diagnosis and prognosis. Open Biol. 9:180212
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rapado-González Ó, Álvarez-Castro A,
López-López R, Iglesias-Canle J, Suárez-Cunqueiro MM and
Muinelo-Romay L: Circulating microRNAs as promising biomarkers in
colorectal cancer. Cancers (Basel). 11:8982019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsukamoto M, Iinuma H, Yagi T, Matsuda K
and Hashiguchi Y: Circulating exosomal MicroRNA-21 as a biomarker
in each tumor stage of colorectal cancer. Oncology. 92:360–370.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Danese E, Minicozzi AM, Benati M, Paviati
E, Lima-Oliveira G, Gusella M, Pasini F, Salvagno GL, Montagnana M
and Lippi G: Reference miRNAs for colorectal cancer: Analysis and
verification of current data. Sci Rep. 7:84132017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen J, Wang W, Zhang Y, Chen Y and Hu T:
Predicting distant metastasis and chemoresistance using plasma
miRNAs. Med Oncol Northwood Lond Engl. 31:7992014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luu-The V, Paquet N, Calvo E and Cumps J:
Improved real-time RT-PCR method for high-throughput measurements
using second derivative calculation and double correction.
Biotechniques. 38:287–293. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Core R: Team: R: A Language and
Environment for Statistical Computing. R Foundation for Statistical
Computing. (Vienna, Austria). 2018.
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vlachos IS, Zagganas K, Paraskevopoulou
MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T and
Hatzigeorgiou AG: DIANA-miRPath v3.0: Deciphering microRNA function
with experimental support. Nucleic Acids Res. 43:W460–W466. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kirschner MB, Kao SC, Edelman JJ,
Armstrong NJ, Vallely MP, van Zandwijk N and Reid G: Haemolysis
during sample preparation alters microRNA content of plasma. PLoS
One. 6:e241452011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Goni R, García P and Foissac S: The qPCR
data statistical analysis. 9. 2009.
|
|
33
|
Chen WY, Zhao XJ, Yu ZF, Hu FL, Liu YP,
Cui BB, Dong XS and Zhao YS: The potential of plasma miRNAs for
diagnosis and risk estimation of colorectal cancer. Int J Clin Exp
Pathol. 8:7092–7101. 2015.PubMed/NCBI
|
|
34
|
Li J, Liu Y, Wang C, Deng T, Liang H, Wang
Y, Huang D, Fan Q, Wang X, Ning T, et al: Serum miRNA expression
profile as a prognostic biomarker of stage II/III colorectal
adenocarcinoma. Sci Rep. 5:129212015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He Y, Wang G, Zhang L, Zhai C, Zhang J,
Zhao X, Jiang X and Zhao Z: Biological effects and clinical
characteristics of microRNA-106a in human colorectal cancer. Oncol
Lett. 14:830–836. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Díaz R, Silva J, García JM, Lorenzo Y,
García V, Peña C, Rodríguez R, Muñoz C, García F, Bonilla F and
Domínguez G: Deregulated expression of miR-106a predicts survival
in human colon cancer patients. Genes Chromosomes Cancer.
47:794–802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yue B, Sun B, Liu C, Zhao S, Zhang D, Yu F
and Yan D: Long non-coding RNA Fer-1-like protein 4 suppresses
oncogenesis and exhibits prognostic value by associating with
miR-106a-5p in colon cancer. Cancer Sci. 106:1323–1332. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Peng Q, Shen Y, Zhao P, Cheng M, Zhu Y and
Xu B: Biomarker roles identification of miR-106 family for
predicting the risk and poor survival of colorectal cancer. BMC
Cancer. 20:5062020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang C, Wang J, Liu H and Fu Z: Tumor
suppressor DLC-1 induces apoptosis and inhibits the growth and
invasion of colon cancer cells through the Wnt/β-catenin signaling
pathway. Oncol Rep. 31:2270–2278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cao H, Huang S, Liu A and Chen Z:
Up-regulated expression of miR-155 in human colonic cancer. J
Cancer Res Ther. 14:604–607. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu N, Jiang F, Han XY, Li M, Chen WJ, Liu
QC, Liao CX and Lv YF: MiRNA-155 promotes the invasion of
colorectal cancer SW-480 cells through regulating the
Wnt/β-catenin. Eur Rev Med Pharmacol Sci. 22:101–109.
2018.PubMed/NCBI
|
|
42
|
Qu A, Du L, Yang Y, Liu H, Li J, Wang L,
Liu Y, Dong Z, Zhang X, Jiang X, et al: Hypoxia-inducible MiR-210
is an independent prognostic factor and contributes to metastasis
in colorectal cancer. PLoS One. 9:e909522014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sabry D, El-Deek SEM, Maher M, El-Baz MAH,
El-Bader HM, Amer E, Hassan EA, Fathy W and El-Deek HEM: Role of
miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in
colorectal carcinoma: Impact of HIF-1α-VEGF signaling pathway. Mol
Cell Biochem. 454:177–189. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ullmann P, Qureshi-Baig K, Rodriguez F,
Ginolhac A, Nonnenmacher Y, Ternes D, Weiler J, Gäbler K, Bahlawane
C, Hiller K, et al: Hypoxia-responsive miR-210 promotes
self-renewal capacity of colon tumor-initiating cells by repressing
ISCU and by inducing lactate production. Oncotarget. 7:65454–65470.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jung EJ, Santarpia L, Kim J, Esteva FJ,
Moretti E, Buzdar AU, Di Leo A, Le XF, Bast RC Jr, Park ST, et al:
Plasma microRNA 210 levels correlate with sensitivity to
trastuzumab and tumor presence in breast cancer patients. Cancer.
118:2603–2614. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wan J, Xia L, Xu W and Lu N: Expression
and function of miR-155 in diseases of the gastrointestinal Tract.
Int J Mol Sci. 17:7092016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rath T, Billmeier U, Waldner MJ, Atreya R
and Neurath MF: From physiology to disease and targeted therapy:
Interleukin-6 in inflammation and inflammation-associated
carcinogenesis. Arch Toxicol. 89:541–554. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Svrcek M, El-Murr N, Wanherdrick K, Dumont
S, Beaugerie L, Cosnes J, Colombel JF, Tiret E, Fléjou JF,
Lesuffleur T and Duval A: Overexpression of microRNAs-155 and 21
targeting mismatch repair proteins in inflammatory bowel diseases.
Carcinogenesis. 34:828–834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ulivi P, Canale M, Passardi A, Marisi G,
Valgiusti M, Frassineti GL, Calistri D, Amadori D and Scarpi E:
Circulating plasma levels of miR-20b, miR-29b and miR-155 as
predictors of bevacizumab efficacy in patients with metastatic
colorectal cancer. Int J Mol Sci. 19:3072018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
You C, Jin L, Xu Q, Shen B, Jiao X and
Huang X: Expression of miR-21 and miR-138 in colon cancer and its
effect on cell proliferation and prognosis. Oncol Lett.
17:2271–2277. 2019.PubMed/NCBI
|
|
52
|
Mima K, Nishihara R, Yang J, Dou R, Masugi
Y, Shi Y, da Silva A, Cao Y, Song M, Nowak J, et al: MicroRNA MIR21
(miR-21) and PTGS2 expression in colorectal cancer and patient
survival. Clin Cancer Res. 22:3841–3848. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Inamura K and Ishikawa Y: MicroRNA in lung
cancer: Novel biomarkers and potential tools for treatment. J Clin
Med. 5:362016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Komatsu S, Ichikawa D, Takeshita H,
Tsujiura M, Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H,
Shiozaki A, et al: Circulating microRNAs in plasma of patients with
oesophageal squamous cell carcinoma. Br J Cancer. 105:104–111.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Saxena A, Tammali R, Ramana KV and
Srivastava SK: Aldose reductase inhibition prevents colon cancer
growth by restoring phosphatase and tensin homolog through
modulation of miR-21 and FOXO3a. Antioxid Redox Signal.
18:1249–1262. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hong Z, Feng Z, Sai Z and Tao S: PER3, a
novel target of miR-103, plays a suppressive role in colorectal
cancer in vitro. BMB Rep. 47:500–505. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zheng YB, Xiao K, Xiao GC, Tong SL, Ding
Y, Wang QS, Li SB and Hao ZN: MicroRNA-103 promotes tumor growth
and metastasis in colorectal cancer by directly targeting LATS2.
Oncol Lett. 12:2194–2200. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang DS, Zhong B, Zhang M-S and Gao Y:
Upregulation of serum miR-103 predicts unfavorable prognosis in
patients with colorectal cancer. Eur Rev Med Pharmacol Sci.
22:4518–4523. 2018.PubMed/NCBI
|
|
59
|
Xu W, Ji J, Xu Y, Liu Y, Shi L, Liu Y, Lu
X, Zhao Y, Luo F, Wang B, et al: MicroRNA-191, by promoting the EMT
and increasing CSC-like properties, is involved in neoplastic and
metastatic properties of transformed human bronchial epithelial
cells. Mol Carcinog. 54 (Suppl 1):E148–E161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhang XF, Li KK, Gao L, Li SZ, Chen K,
Zhang JB, Wang D, Tu RF, Zhang JX, Tao KX, et al: miR-191 promotes
tumorigenesis of human colorectal cancer through targeting C/EBPβ.
Oncotarget. 6:4144–4158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Qin S, Zhu Y, Ai F, Li Y, Bai B, Yao W and
Dong L: MicroRNA-191 correlates with poor prognosis of colorectal
carcinoma and plays multiple roles by targeting tissue inhibitor of
metalloprotease 3. Neoplasma. 61:27–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Milanesi E, Dobre M, Bucuroiu AI, Herlea
V, Manuc TE, Salvi A, De Petro G, Manuc M and Becheanu G:
miRNAs-based molecular signature for KRAS mutated and wild type
colorectal cancer: An explorative study. J Immunol Res.
2020:49271202020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chen XY, Zhang J, Hou LD, Zhang R, Chen W,
Fan HN, Huang YX, Liu H and Zhu JS: Upregulation of PD-L1 predicts
poor prognosis and is associated with miR-191-5p dysregulation in
colon adenocarcinoma. Int J Immunopathol Pharmacol.
32:20587384187903182018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Qian J, Jiang B, Li M, Chen J and Fang M:
Prognostic significance of microRNA-16 expression in human
colorectal cancer. World J Surg. 37:2944–2949. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Xiao G, Tang H, Wei W, Li J, Ji L and Ge
J: Aberrant expression of MicroRNA-15a and MicroRNA-16
synergistically associates with tumor progression and prognosis in
patients with colorectal cancer. Gastroenterol Res Pract.
2014:3645492014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Ma Q, Wang X, Li Z, Li B, Ma F, Peng L,
Zhang Y, Xu A and Jiang B: microRNA-16 represses colorectal cancer
cell growth in vitro by regulating the p53/survivin signaling
pathway. Oncol Rep. 29:1652–1658. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Diamantopoulos MA, Kontos CK, Kerimis D,
Papadopoulos IN and Scorilas A: Upregulated miR-16 expression is an
independent indicator of relapse and poor overall survival of
colorectal adenocarcinoma patients. Clin Chem Lab Med. 55:737–747.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ostenfeld MS, Jensen SG, Jeppesen DK,
Christensen LL, Thorsen SB, Stenvang J, Hvam ML, Thomsen A,
Mouritzen P, Rasmussen MH, et al: miRNA profiling of circulating
EpCAM(+) extracellular vesicles: Promising biomarkers of colorectal
cancer. J Extracell Vesicles. 5:314882016. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Evans C, Hardin J and Stoebel D: Selecting
between-sample RNA-Seq normalization methods from the perspective
of their assumptions. Brief Bioinform. 19:776–792. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Dillies MA, Rau A, Aubert J,
Hennequet-Antier C, Jeanmougin M, Servant N, Keime C, Marot G,
Castel D, Estelle J, et al: A comprehensive evaluation of
normalization methods for Illumina high-throughput RNA sequencing
data analysis. Brief Bioinform. 14:671–683. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Fundel K, Haag J, Gebhard PM, Zimmer R and
Aigner T: Normalization strategies for mRNA expression data in
cartilage research. Osteoarthritis Cartilage. 16:947–955. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Rieder F, Brenmoehl J, Leeb S, Schölmerich
J and Rogler G: Wound healing and fibrosis in intestinal disease.
Gut. 56:130–139. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Theocharis AD, Skandalis SS, Gialeli C and
Karamanos NK: Extracellular matrix structure. Adv Drug Deliv Rev.
97:4–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Howell JC and Wells JM: Generating
intestinal tissue from stem cells: Potential for research and
therapy. Regen Med. 6:743–755. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Xue X and Falcon DM: The role of immune
cells and cytokines in intestinal wound healing. Int J Mol Sci.
20:60972019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wang Y, Yu A and Yu FX: The Hippo pathway
in tissue homeostasis and regeneration. Protein Cell. 8:349–359.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wang H, Li X, Lu J, Jones P and Xu W:
Prolactin may serve as a regulator to promote vocal fold wound
healing. Biosci Rep. 40:BSR202004672020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Shantha Kumara H, Yan X-H, Pettke E, Cekic
V, Gandhi ND, Bellini GA and Whelan RL: Plasma and wound fluid
levels of eight proangiogenic proteins are elevated after
colorectal resection. World J Gastrointest Oncol. 11:470–488. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Mizuno R, Kawada K, Itatani Y, Ogawa R,
Kiyasu Y and Sakai Y: The role of tumor-associated neutrophils in
colorectal cancer. Int J Mol Sci. 20:5292019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Roma-Rodrigues C, Mendes R, Baptista PV
and Fernandes AR: Targeting tumor microenvironment for cancer
therapy. Int J Mol Sci. 20:8402019. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Kasprzak A: The role of tumor
microenvironment cells in colorectal cancer (CRC) cachexia. Int J
Mol Sci. 22:15652021. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Bonnans C, Chou J and Werb Z: Remodelling
the extracellular matrix in development and disease. Nat Rev Mol
Cell Biol. 15:786–801. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Salesse S, Odoul L, Chazée L, Garbar C,
Duca L, Martiny L, Mahmoudi R and Debelle L: Elastin molecular
aging promotes MDA-MB-231 breast cancer cell invasiveness. FEBS
Open Bio. 8:1395–1404. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Greten FR and Grivennikov SI: Inflammation
and Cancer: Triggers, Mechanisms, and Consequences. Immunity.
51:27–41. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Triner D and Shah YM: Hypoxia-inducible
factors: A central link between inflammation and cancer. J Clin
Invest. 126:3689–3698. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Li J, Xu X, Jiang Y, Hansbro NG, Hansbro
PM, Xu J and Liu G: Elastin is a key factor of tumor development in
colorectal cancer. BMC Cancer. 20:2172020. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Sommer K, Wiendl M, Müller TM, Heidbreder
K, Voskens C, Neurath MF and Zundler S: Intestinal mucosal wound
healing and barrier integrity in IBD-crosstalk and trafficking of
cellular players. Front Med (Lausanne). 8:6439732021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Monnet E and Smeak DD: Gastrointestinal
healing. In Gastrointestinal Surgical Techniques in Small Animals.
Monnet E and Smeak DD (eds). Wiley Blackwell. (Hoboken, NJ, USA, pp
1-8). 2020.
|
